Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 31.53 | 28.12 | 28.97 | 42.71 |
Depreciation/ Depletion | 3.34 | 2.60 | 2.37 | 2.22 |
Non- Cash Items | 1.53 | 1.09 | 1.15 | 1.94 |
Changesin Working Capital | -15.24 | -10.63 | -10.45 | -27.78 |
Cashfrom Operating Activities | 21.15 | 21.18 | 22.04 | 19.08 |
Capital Expenditures | -20.60 | -13.17 | -13.68 | -4.86 |
Other Investing Cash Flow Items Total | 0.29 | -7.56 | -2.76 | - |
Cashfrom Investing Activities | -20.30 | -20.73 | -16.44 | -4.86 |
Financing Cash Flow Items | -1.17 | -0.75 | -0.87 | -1.67 |
Total Cash Dividends Paid | -1.49 | -1.24 | -1.24 | -0.83 |
Issuance( Retirement)of Debt Net | -0.21 | -0.42 | -1.99 | -8.11 |
Cashfrom Financing Activities | -2.87 | -2.40 | -4.10 | -10.60 |
Net Changein Cash | -2.02 | -1.95 | 1.51 | 3.62 |
Cash Taxes Paid | 7.87 | 7.50 | 7.12 | 10.88 |
Titan Biotech Dividend Titan Biotech Bonus Titan Biotech News Titan Biotech AGM Titan Biotech Rights Titan Biotech Splits Titan Biotech Board Meetings Titan Biotech Key Metrics Titan Biotech Shareholdings Titan Biotech Profit Loss Titan Biotech Balance Sheet Titan Biotech Q1 Results Titan Biotech Q2 Results Titan Biotech Q3 Results Titan Biotech Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks